NCM
GILD icon

NCM Capital Management’s Gilead Sciences GILD Stock Holding History

NCM Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.38M Sell
9,899
-48
-0.5% -$6.72K 0.49% 54
2025
Q4 		$1.22M Sell
9,947
-203
-2% -$24.7K 0.45% 55
2025
Q3 		$1.13M Buy
10,150
+3
+0% +$341 0.44% 58
2025
Q2 		$1.13M Buy
10,147
+2
+0% +$213 0.46% 53
2025
Q1 		$1.14M Buy
10,145
+3
+0% +$310 0.51% 48
2024
Q4 		$937K Sell
10,142
-53
-0.5% -$4.77K 0.42% 56
2024
Q3 		$855K Sell
10,195
-97
-0.9% -$7.4K 0.41% 60
2024
Q2 		$706K Buy
10,292
+3
+0% +$200 0.37% 68
2024
Q1 		$754K Sell
10,289
-96
-0.9% -$7.38K 0.42% 63
2023
Q4 		$841K Buy
10,385
+203
+2% +$15.8K 0.51% 54
2023
Q3 		$763K Buy
10,182
+3
+0% +$231 0.54% 52
2023
Q2 		$784K Sell
10,179
-211
-2% -$16.8K 0.55% 52
2023
Q1 		$862K Buy
10,390
+4
+0% +$331 0.64% 49
2022
Q4 		$892K Sell
10,386
-146
-1% -$11.6K 0.59% 49
2022
Q3 		$650K Buy
10,532
+5
+0% +$315 0.49% 66
2022
Q2 		$651K Sell
10,527
-145
-1% -$8.98K 0.46% 71
2022
Q1 		$634K Sell
10,672
-1,877
-15% -$120K 0.4% 84
2021
Q4 		$911K Buy
+12,549
New +$864K 0.81% 39

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

NCM Capital Management's GILD Position: Q1 2026 in Review

NCM Capital Management reduced its Gilead Sciences (GILD) stake by 0.48% in Q1 2026, selling an estimated $6.72K and leaving 9,899 shares worth $1.38M. The position accounts for 0.49% of the portfolio, ranked #54.

NCM Capital Management first reported a position in GILD in Q4 2021 and has held it in 18 quarters since. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • NCM Capital Management held 9,899 shares of Gilead Sciences worth $1.38M as of Q1 2026.
  • NCM Capital Management sold 48 Gilead Sciences shares in Q1 2026, an estimated $6.72K.
  • Gilead Sciences made up 0.49% of NCM Capital Management's portfolio in Q1 2026, its #54 holding.
  • NCM Capital Management first reported a position in Gilead Sciences in Q4 2021 and has held it in 18 quarters since.
  • 2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on NCM Capital Management's 13F filing for Q1 2026, filed 15 May 2026.